Invention Grant
US08497247B2 Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule
有权
通过施用可溶性CTLA4分子治疗I型糖尿病的方法
- Patent Title: Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule
- Patent Title (中): 通过施用可溶性CTLA4分子治疗I型糖尿病的方法
-
Application No.: US13404384Application Date: 2012-02-24
-
Publication No.: US08497247B2Publication Date: 2013-07-30
- Inventor: Robert Cohen , Suzette Carr , David Hagerty , Robert James Peach , Jean-Claude Becker
- Applicant: Robert Cohen , Suzette Carr , David Hagerty , Robert James Peach , Jean-Claude Becker
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Nickki Parlet
- Main IPC: A61K38/16
- IPC: A61K38/16
Abstract:
The present invention relates to compositions and methods for treating autoimmune diseases, such as diabetes, by administering to a subject a CTLA4 molecule that block endogenous B7 molecules from binding their ligands.
Public/Granted literature
- US20120258094A1 METHOD FOR TREATING A RHEUMATIC DISEASE USING A SOLUBLE CTLA4 MOLECULE Public/Granted day:2012-10-11
Information query
IPC分类:
